Triazolopyrimidine compounds and uses thereof
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein. 
Novartis AG
A A A A A C A A A
A61K A61P A61K A61K A61K C07D A61P A61K A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional
Hailong Ling Ji Yue (Jeff) Qiong Long Ho Man Yongfeng Man Wei Xiang-Ju Justin Zhengtian Ying Yuan Martin Kehao
Zhang Li Zhang Zhang Wang Chan Sun Zhang Qi Gu Yu Huang Mi Sendzik Zhao